68 related articles for article (PubMed ID: 20045672)
1. A sensitive HIV-1 envelope induced fusion assay identifies fusion enhancement of thrombin.
Cheng DC; Zhong GC; Su JX; Liu YH; Li Y; Wang JY; Hattori T; Ling H; Zhang FM
Biochem Biophys Res Commun; 2010 Jan; 391(4):1780-4. PubMed ID: 20045672
[TBL] [Abstract][Full Text] [Related]
2. An inducible cell-cell fusion system with integrated ability to measure the efficiency and specificity of HIV-1 entry inhibitors.
Herschhorn A; Finzi A; Jones DM; Courter JR; Sugawara A; Smith AB; Sodroski JG
PLoS One; 2011; 6(11):e26731. PubMed ID: 22069466
[TBL] [Abstract][Full Text] [Related]
3. Role of envelope processing and gp41 membrane spanning domain in the formation of human immunodeficiency virus type 1 (HIV-1) fusion-competent envelope glycoprotein complex.
Welman M; Lemay G; Cohen EA
Virus Res; 2007 Mar; 124(1-2):103-12. PubMed ID: 17129629
[TBL] [Abstract][Full Text] [Related]
4. Inhibitory effects of small-molecule CCR5 antagonists on human immunodeficiency virus type 1 envelope-mediated membrane fusion and viral replication.
Takashima K; Miyake H; Furuta RA; Fujisawa JI; Iizawa Y; Kanzaki N; Shiraishi M; Okonogi K; Baba M
Antimicrob Agents Chemother; 2001 Dec; 45(12):3538-43. PubMed ID: 11709336
[TBL] [Abstract][Full Text] [Related]
5. Modification of a viral envelope glycoprotein cell-cell fusion assay by utilizing plasmid encoded bacteriophage RNA polymerase.
Lin G; Murphy SL; Gaulton GN; Hoxie JA
J Virol Methods; 2005 Sep; 128(1-2):135-42. PubMed ID: 15941597
[TBL] [Abstract][Full Text] [Related]
6. HIV-1 coreceptor activity of CCR5 and its inhibition by chemokines: independence from G protein signaling and importance of coreceptor downmodulation.
Alkhatib G; Locati M; Kennedy PE; Murphy PM; Berger EA
Virology; 1997 Aug; 234(2):340-8. PubMed ID: 9268166
[TBL] [Abstract][Full Text] [Related]
7. Development and automation of a 384-well cell fusion assay to identify inhibitors of CCR5/CD4-mediated HIV virus entry.
Bradley J; Gill J; Bertelli F; Letafat S; Corbau R; Hayter P; Harrison P; Tee A; Keighley W; Perros M; Ciaramella G; Sewing A; Williams C
J Biomol Screen; 2004 Sep; 9(6):516-24. PubMed ID: 15452338
[TBL] [Abstract][Full Text] [Related]
8. [Inhibition of HIV-1 mediated cell-cell fusion by saponin fraction from Psidium guajava leaf].
Mao QC; Zhou YC; Li RM; Hu YP; Liu SW; Li XJ
Zhong Yao Cai; 2010 Nov; 33(11):1751-4. PubMed ID: 21434438
[TBL] [Abstract][Full Text] [Related]
9. Use of new T-cell-based cell lines expressing two luciferase reporters for accurately evaluating susceptibility to anti-human immunodeficiency virus type 1 drugs.
Chiba-Mizutani T; Miura H; Matsuda M; Matsuda Z; Yokomaku Y; Miyauchi K; Nishizawa M; Yamamoto N; Sugiura W
J Clin Microbiol; 2007 Feb; 45(2):477-87. PubMed ID: 17182760
[TBL] [Abstract][Full Text] [Related]
10. HIV-1 gp41: mediator of fusion and target for inhibition.
Weiss CD
AIDS Rev; 2003; 5(4):214-21. PubMed ID: 15012000
[TBL] [Abstract][Full Text] [Related]
11. Ezrin, Radixin, and Moesin (ERM) proteins function as pleiotropic regulators of human immunodeficiency virus type 1 infection.
Kubo Y; Yoshii H; Kamiyama H; Tominaga C; Tanaka Y; Sato H; Yamamoto N
Virology; 2008 May; 375(1):130-40. PubMed ID: 18295815
[TBL] [Abstract][Full Text] [Related]
12. Macrophage-tropic HIV and SIV envelope proteins induce a signal through the CCR5 chemokine receptor.
Weissman D; Rabin RL; Arthos J; Rubbert A; Dybul M; Swofford R; Venkatesan S; Farber JM; Fauci AS
Nature; 1997 Oct; 389(6654):981-5. PubMed ID: 9353123
[TBL] [Abstract][Full Text] [Related]
13. The role of cholesterol and sphingolipids in chemokine receptor function and HIV-1 envelope glycoprotein-mediated fusion.
Ablan S; Rawat SS; Viard M; Wang JM; Puri A; Blumenthal R
Virol J; 2006 Dec; 3():104. PubMed ID: 17187670
[TBL] [Abstract][Full Text] [Related]
14. Novel, rapid assay for measuring entry of diverse enveloped viruses, including HIV and rabies.
Saeed MF; Kolokoltsov AA; Davey RA
J Virol Methods; 2006 Aug; 135(2):143-50. PubMed ID: 16584792
[TBL] [Abstract][Full Text] [Related]
15. Peptide P5 (residues 628-683), comprising the entire membrane proximal region of HIV-1 gp41 and its calcium-binding site, is a potent inhibitor of HIV-1 infection.
Yu H; Tudor D; Alfsen A; Labrosse B; Clavel F; Bomsel M
Retrovirology; 2008 Oct; 5():93. PubMed ID: 18925934
[TBL] [Abstract][Full Text] [Related]
16. [1,2,6-tri-O-galloyl-beta-D-glucopyranose inhibits gp41-mediated HIV envelope fusion with target cell membrane].
Sun W; Wang HT; Xia CL; Wu SG; Jiang SB; Jiang ZH; Liu SW
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Jul; 28(7):1127-31. PubMed ID: 18676243
[TBL] [Abstract][Full Text] [Related]
17. Actin cytoskeletal reorganizations and coreceptor-mediated activation of rac during human immunodeficiency virus-induced cell fusion.
Pontow SE; Heyden NV; Wei S; Ratner L
J Virol; 2004 Jul; 78(13):7138-47. PubMed ID: 15194790
[TBL] [Abstract][Full Text] [Related]
18. Differential inhibition of HIV-1 and SIV envelope-mediated cell fusion by C34 peptides derived from the C-terminal heptad repeat of gp41 from diverse strains of HIV-1, HIV-2, and SIV.
Gustchina E; Hummer G; Bewley CA; Clore GM
J Med Chem; 2005 Apr; 48(8):3036-44. PubMed ID: 15828842
[TBL] [Abstract][Full Text] [Related]
19. HIV and SIV gp120 binding does not predict coreceptor function.
Baik SS; Doms RW; Doranz BJ
Virology; 1999 Jul; 259(2):267-73. PubMed ID: 10388651
[TBL] [Abstract][Full Text] [Related]
20. Use of GPR1, GPR15, and STRL33 as coreceptors by diverse human immunodeficiency virus type 1 and simian immunodeficiency virus envelope proteins.
Edinger AL; Hoffman TL; Sharron M; Lee B; O'Dowd B; Doms RW
Virology; 1998 Sep; 249(2):367-78. PubMed ID: 9791028
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
